Press Release: Trivedi Global, Inc. and Cathryn Nykvist Announce Research Results on the Impact of a Biofield Energy Treated Nutraceutical to Combat Inflammation and Autoimmune Disorders (Globe Newswire)
Winnipeg, Manitoba, Canada, June 02, 2018 (Click Here to view on GLOBE NEWSWIRE)
Cathryn Nykvist, an evidence-based energy healer, today announces research results on the impact of a biofield energy treated nutraceutical to reduce inflammation and autoimmune disorders and improve overall immune response.
The preclinical research assessed biomarkers for immune function and blood, as well as, inflammation. The following data was reported:
- Over 180% increase in overall immunity as seen by elevation of antibody levels
- Over 20% decrease in uric acid levels
- Significant improvement in blood cell count, increased delayed-type hypersensitivity reaction and magnesium levels
The research suggests that this biofield energy treatment enhanced the nutraceutical’s anti-inflammatory and immunomodulatory properties. Additionally, the treated formulation was reported to improve stress management, as well as, anti-aging by enhancing overall health and quality of life.
Further, the results indicate the potential to combat inflammation, which is the root cause of many of the most common diseases today.
Overall, this energy infused nutraceutical shows great promise as a complementary and alternative medicine (CAM) supplement, with a safe therapeutic index. It can be used to combat various autoimmune disorders such as Lupus, Addison’s Disease, Celiac Disease (gluten-sensitive enteropathy), Dermatomyositis, Graves’ Disease, Hashimoto Thyroiditis, Multiple Sclerosis, Myasthenia Gravis, Pernicious Anemia, Aplastic Anemia, Reactive Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, Systemic Lupus Erythematosus, Type 1 Diabetes, Alopecia Areata, Crohn’s Disease, Fibromyalgia, Vitiligo, Psoriasis, Scleroderma, Chronic Fatigue Syndrome and Vasculitis. It has potential to fight inflammatory disorders such as Asthma, Ulcerative Colitis, Alzheimer’s Disease, Atherosclerosis, Dermatitis, Diverticulitis, Hepatitis, Irritable Bowel Syndrome, Parkinson’s Disease and Irritable Bowel Syndrome (IBS). Additionally, the nutraceutical shows promise in the prevention of immune-mediated tissue damage in cases of organ transplants.
This Biofield Energy Healing Treatment was provided by Nykvist as part of a group of 18 energy healers. Eleven were remotely located in the U.S.A., four in Canada and one each in the United Kingdom, Russia, and Ireland. The test formulation was located in the research laboratory of Dabur Research Foundation, near New Delhi, India. The Biofield Energy Treatment was administered for 5 minutes through the healers’ unique Biofield Energy Transmission process remotely to the test samples under laboratory conditions. Nykvist, as well as, the other 17 biofield healers participating in this research never visited the laboratory in person, nor had any contact with the nutraceutical samples.
About Biofield Energy Treatments
The National Center of Complementary and Integrative Health (NCCIH) has recognized and accepted Biofield Energy Healing Treatments as a complementary and alternative medicine (CAM) health care approach in addition to other therapies, medicines, and practices. CAM therapies have been practiced worldwide with reported clinical benefits in different health disease profiles. Human Biofield Energy has subtle energy that has the capacity to work in an effective manner. This energy can be harnessed and transmitted by the gifted into living and non-living things via the process of a Biofield Energy Healing Treatment or Therapy.
Title: Assessment of Immunomodulatory Activity of the Biofield Energy Treated Novel Herbomineral Formulation After Oral Administration in Female Sprague Dawley Rats
Journal: International Journal of Biomedical Engineering and Clinical Science
Published: November 30, 2017
About Cathryn Nykvist
Cathryn Nykvist is a natural born healer. She has been a lifelong seeker of alternative healing knowledge and spiritualism. Her curiosity, authenticity, and integrity led her to an association with Guruji Mahendra Trivedi, founder of Trivedi Global, Inc. and the Trivedi Effect®. Nykvist’s healing power is validated in preclinical scientific research using both cell-based and mouse models to suggest benefits from her energy transmissions for overall health and well-being, as well as, an improved quality of life. Further, an increased level of Vitamin D3 in bone health has been indicated through her energy transmissions.
About Guruji Mahendra Trivedi & The Trivedi Effect® About Guruji Mahendra Trivedi & The Trivedi Effect
Guruji Mahendra Kumar Trivedi, the founder of the Trivedi Effect®, is on a mission to usher in a new era that integrates science, spirituality, and consciousness to vastly improve the human condition and benefit humanity on a global scale. To date, more than 250,000 people worldwide have benefited from the Trivedi Effect®. His organization, Trivedi Global, Inc., is collaborating with globally renowned product research and development organizations to bring to market proprietary products and therapies in the areas of nutraceuticals, pharmaceuticals, and more. Alice Branton, CEO, Trivedi Global, Inc., recently spoke on the impact of the Trivedi Effect® at the Entrepreneurship Club of the Harvard Business School, Nasdaq, Microsoft, and Coca-Cola. She also appeared on more than 35 network television news shows in the last year including ABC, NBC, FOX, CW and more. Dahryn Trivedi, a prodigious spiritual leader, young entrepreneur, inspiring speaker and paradigm-shifting scientist also joins in the mission.
The Trivedi Effect® is an evidence-based phenomenon in which an individual can harness inherently intelligent energy from nature and transmit it to living organisms and non-living materials, anywhere in the world through thought intention, to significantly enhance potency and beneficially alter their characteristics and behaviors through transformation at the atomic, molecular, and cellular levels.
The Trivedi Effect® has been tested, measured, and validated in over 4,000 scientific experiments globally, by world-renowned scientists and research institutes using the rigor of internationally accepted models of scientific research with the most sophisticated technologies available on this planet. Challenging the known frontiers of science, this research has resulted in over 350 publications in major international peer-reviewed scientific journals with over 4,000 citations.
These publications are available in over 3,500 universities internationally including the prestigious Ivy League Universities, as well as, the National Institutes of Health (NIH).
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause actual results in future periods to differ materially from stated results. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, and orientations regarding the future. Often, but not always, forward-looking statements can be identified by words such as “may”, “will”, “should”, “would”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “future”, “continue”, “appear”, or variations of such words including negative variations thereof, and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved.